INTRODUCTION
Chronic obstructive pulmonary disease (COPD) has been defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) as a disease state characterized by airflow limitation which is not fully reversible. Measurement of lung function is the key test necessary for diagnosis of COPD but individually it is not sufficient to predict the morbidity. COPD is a disease of increasing public health importance around the world. GOLD estimates suggest that COPD will rise from the sixth to the third most common cause of death worldwide by 2020. 1, 2, 3 COPD is a disease of increasing public health importance around the world. GOLD estimates suggest that COPD will rise from the sixth to the third most common cause of death worldwide by 2020. The WHO estimates that it will become the third leading cause of death in 2020. COPD is associated with significant extra-pulmonary (systemic) effects among which cardiac complications are most common. Cardiovascular disease accounts for approximately 50% of all hospitalization and nearly one-third of all deaths in cases where (FEV1) is 50% of predicted. 4 So, a timely prediction about the cardiac involvement is of vital importance. COPD affects primarily the right side of heart and echocardiography provides a rapid, non-invasive and accurate method to evaluate the RV functions along with left ventricular function. Cardiac function is often impaired in this disease, but its association with clinical outcome has not been fully established. 4 Pulmonary arterial hypertension (PHT) is a common complication of COPD and the increase in pulmonary artery pressure is often mild to moderate. The presence of pulmonary arterial pressure and its severity is readily and reliably determined by transthoracic echocardiography (TTE) in majority of COPD patients. 3, 5 Because transthoracic echocardiography is an inexpensive, easy, and reproducible method, it is the most commonly used noninvasive diagnostic tool to determine pulmonary artery pressure (PAP). Tissue Doppler imaging (TDI) emerged as a new echocardiographic method that can be applied in various clinical conditions. Relation of spirometric parameters in COPD with echocardiographic findings is not well established so far. The purpose of our study was to evaluate parameters of Tissue Doppler imaging (TDI), LV and RV functions (systolic and diastolic), RV and LV dimensions and pulmonary hypertension in patients of different stages of COPD by echocardiography as per guidelines of American Society of Echocardiography with an aim to find a simple way of predicting cardiac morbidity in COPD. To evaluate RV and LV function in COPD as per guidelines of American Society of Echocardiography (ASE).
Journal of Cardiovascular Disease Research, Vol 7, Issue 1, Jan-Mar, 2016 echocardiography (TTE) and Doppler examination. All the subjects fulfilling inclusion criteria of COPD attaining Medicine OPD underwent spirometric examination and through echocardiographic and Doppler evaluation as per standard protocol and guidelines of American Society of Echocardiography (ASE). Inclusion criteria: All consecutive patients with history, clinical examination and spirometric diagnosis of COPD with age >30 and ≤ 60 years with no other possibility of alternative diagnosis of both the genders were included in the study. Written and informed consent (ICMR) was obtained before enrolling patient in the study. Exclusion criteria: Age less than 30 and more than 60 years, IHD, HTN, restrictive lung disease, lung disease other than COPD, Hemoglobin less than 10 gm%, critically ill patient, LV systolic dysfunction, acute pulmonary thrombo-embolism, patient who not able to perform pulmonary function tests (PFT) or Echocardiography, poor echo window, subjects with intra-cardiac shunt. Subjects with significant renal or hepatic dysfunction, acute exacerbation and resting SpO 2 < 85% were excluded from the study. In addition, we excluded patients with other causes of primary pulmonary hypertension such as interstitial lung disease, sleep-disordered breathing, and alveolar hypoventilation disorders, other pulmonary diseases with mixed restrictive and obstructive pattern, vasculitis, pneumoconiosis, congenital heart disease, and occlusion of pulmonary veins syndrome. All selected patients were subjected to routine investigations, including complete blood count, lipid profile, blood sugar, blood urea, serum creatinine, electrocardiography and other investi gations as needed.
Aims & Objectives 1. To assess the cardiac changes secondary to COPD by echocardiography (TTE) 2. To study various parameters of diastolic function and to assess the parameters of Tissue Doppler imaging (TDI) 3. To find out relation of TDI parameters with spirometric variables. 4. To find out the correlation between echocardiographic and TDI parameters to the stages of COPD by GOLD criteria. Spirometry: All the patients were investigated by spirometry with electronic spirometer (model: Recorders and Medicare systems [RMS] Helios 702). The PFTs parameters included were FEV1, FVC, FEV1/FVC ratio, PEFR, FEF25-75. The results of the PFTs were recorded in percent of predicted values. All the patients were investigated by spirometry and diagnosed and classified according to GOLD guidelines (postbronchodilator FEV 1 /forced vital capacity (FVC) ratio < 70% predicted), mild (FEV 1 ≥ 80% of predicted), moderate (50% ≤ FEV 1 < 80% predicted), severe (30% ≤ FEV 1 < 50% predicted) and very severe (FEV 1 < 30% predicted) respectively. 6,7 Trasthoracic 2-dimensional Echocardiogram and Doppler: All the patients were subjected to echocardiography using model: Acuson X-300, Siemens with adult cardiac probe: 3-5 MHz. All patients were subjected to resting 2-dimension transthoracic echocardiography, M-mode, and Doppler (PW, CW, CFM and TDI) study according to standard protocol, in the cardiology department of KIMSDU Karad. Echocardiography was reviewed to assess the pericardium, valvular anatomy and function, left and right side chamber size and cardiac function. Tricuspid regurgitant (TR) flow was identified by color flow Doppler technique and the maximum jet velocity was measured by continuous wave Doppler. Diastolic function was assessed by PW, IVRT, DT, VP and tissue Doppler imaging (TDI). Right ventricular systolic pressure (RVSP/sPAP) was estimated based on the modified Bernoulli equation and was considered to be equal to the sPAP in the absence of right ventricular outflow obstruction: sPAP (mmHg)=right ventricular systolic pressure=trans-tricuspid pressure gradient (TTPG)+right atrial pressure (RAP), where trans-tricuspid gradient is 4×v 2 (v=peak velocity of tricuspid regurgitation in m/s). Right atrial pressure (RAP) was estimated to be 5, 10, or 15 mmHg based on the variation in the size of inferior vena cava with inspiration as follows: complete collapse, RAP=5 mmHg; partial collapse, RAP=10 mmHg; and no collapse, RAP=15 mmHg. RVSP=4(vTR) 2 +RAP, where vTR is peak TR velocity (m/s) and RAP is mean right atrial pressure (mmHg) as per American Society of Echocardiography (ASE) recommendations. 8, 9 Pulmonary hypertension (PH) was defined in this study as sPAP ≥ 30 mmHg. This value was chosen according to the definition of pulmonary hypertension. PH was classified into mild, moderate, and severe category as sPAP 30-50, 50-70, >70 mmHg, respectively (using Chemla formula, mean pulmonary arterial pressure (MPAP) =0.61 PASP+2 mmHg and putting value of [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] , and >45 mmHg of MPAP for mild, moderate, and severe pulmonary hypertension, respectively). Right ventricle dimension was measured by M-Mode echo and right ventricular dilation or cor pulmonale was said to be present when it exceeded the normal range of 0.9-2.6 cm. Right ventricle contractility was also noted and right ventricular systolic dysfunction was said to be present when it was hypokinetic. Left ventricular function was also assessed by using the following parameters: EF (ejection fraction)=measure of how much end-diastolic value is ejected from LV with each contraction (56%-78%). FS (fractional shortening)=it is a percentage change in LV dimension with each LV contraction (28%-44%). LV mass=left ventricular mass (Normal: 88-224 g). E/A=diastolic filling of left ventricles usually classified initially on the basis of the peak mitral flow velocity of the early rapid filling wave (E), peak velocity of the late filling wave caused by atrial contraction (A). In normal subjects LV elastic recoil is vigorous because of normal myocardial relaxation, therefore more filling is completed during early diastolic, so left ventricular diastolic dysfunction (LVDD) is said to be present when E/A is <1.3 (age group 45-49 years), <1.2 (age group 50-59 years), <1.0 (age group 60-69 years), and <0.8 (age group ≥70 years). The echocardiography parameters were RV basal, mid-level and apical diameter, RV wall thickness, right atrial major and minor dimensions, TAPSE, RVMPI, FAC%, sPAP, LVEF %, Diastolic function by Pulse wave (E, A, E/A ratio, IVRT and DT) and Tissue Doppler imaging [Ea(m), Aa (m), Ea (l), Aa (l), Sa (m), Sa (l), IVRT, E/Ea ratio and DT] and velocity propagation (VP).
9-11 ( Figure 1 , 2, 3 and 4). Statistical analysis: All data collected were analyzed by trial SPSS version-14 for mean, SD, percent, chi-square test and correlation coefficient. A value of 'p' < 0.05 was considered as statistically significant.
RESULTS
A total 60 patients (34 [56.66%] males and 26 [43. 33%] females) fulfilling inclusion criteria of study with COPD were enrolled for observational prospective study. The mean age for male population was (45.6 years (±14.4) and for female population was 48.7 years (±11.2) with 'p'=0.273 (insignificant). The mean and standard deviation for various demographic, clinical and spirometric variables were studied (Table 1) . Total 24 subjects were smoker (SMK) with mean duration of 23.5 years (±6.5). The mean and standard deviation for echocardiogram and Doppler (PW, CW, TDI, IVRT, IVCT, VP and DT) parameters, systolic function and diastolic function were calculated (Table 2, 3 and 4). The GOLD stage-I and II (75%) were significantly more compared to stage II and IV (25%) with 'p'=0.00013 (significant) ( Table 5 and 6 ). Total 5 with stage-I (mild) COPD and 2 with stage-II (moderate) COPD by GOLD criteria had normal resting echocardiogram and Doppler study (11.66%). Total 22 (36.66%) subjects had pulmonary hypertension. Stage -II and IV had significant prevalence of pulmonary hypertension compared to stage-I and II with 'p'=0.000234[Chi-sq=20.49: DF: 3]. Of total 22 (36.66%) subjects total 9 with stage-I and II COPD had mild PH, 7 with stage-III had moderate PH and 6 with stage IV had Severe (30%< FEV1 < 50% predicted) 9 15
Very severe (FEV1 < 30% predicted) 6 10 
DISCUSSION
The cardiac manifestations of COPD are numerous. COPD is associated with significant extra-pulmonary effects including cardiac complications. Impairment of RV function and alteration of pulmonary blood vessels are well known to complicate the clinical course of COPD and correlate inversely with survival. Patients with suspected pulmonary hypertension (PH) should be evaluated using a multimodality approach which includes series of investigations like, echocardiogram and right heart catheterisation (gold standard). Current guidelines recommend that a detailed echocardiographic assessment should be performed in all patients with anticipated PH. Pulmonary hypertension (PH) is defined as an increase in mean pulmonary arterial pressure (PAP) to >25 mmHg at rest as measured by right heart catheterisation (RHC).
12
The studies have confirmed the close correlation of echocardiography estimated pulmonary arterial pressure with invasive measurements (RCH) in patients with chronic obstructive pulmonary disease (COPD), but there are few data on utility of echocardiographic measurement in assessing pulmonary arterial hypertension in COPD and correlation with pulmonary function tests. 13 COPD is not only a major cause of morbidity and mortality, but is also the major reason for intensive care unit (ICU) admission. Cardiac function is often impaired in this disease, but its association with clinical outcome has not been fully established.
14
In view of the adverse effects of pulmonary arterial hypertension on morbidity and mortality routine echocardiography in patients with COPD may be warranted. Echocardiography helps in early detection of cardiac complications in COPD cases giving opportunity for early interventions.
12 Doppler imaging (TDI) velocities seem to be the underutilized and best tool used in the actual practice. COPD is commonly associated with heart failure. Correct interpretation of echocardiographic findings and lung function tests can also help establish the co-occurrence of both conditions. 15 Increase in pulmonary artery pressure (PAP) in COPD, is a predictor of mortality independent of airflow limitation. Pulmonary hypertension is an independent risk factor for death in patients with COPD. Current prognostic models of COPD do not include sufficient indicators of right ventricular (RV) function to enable accurate assessment of changes in RV function over time. It is valuable to add assessment of RV function to the routine evaluation of physical status in patients with COPD. 3 In present cohort of COPD, cor pulmonale was present in 8 (13.33%) subjects and incidence of diastolic dysfunction was 78.33% better measured by TDI. The difference of cor pulmonale and diastolic dysfunction incidence could be due to difference of population characteristics pertaining to COPD and variability of demographic parameters.
Relation of pulmonary hypertension, RV size to spirometric variables:
In present study RVSP (PAP) measured by TR suggestive of PH present in 22 (36.66%) with mean age of 48.7 (± 10.3). The increase in PAP was negatively correlated with FEV1 and positively correlated with severity of COPD. Similarly Kassim M et al (2009) studied 55 patients (65.6 ± 8.2 years) with COPD and found that, TR jet was found in 70.9% of patients with increased PAP in 51% of patients. There were significant associations between echo findings of increasing RV size, TR, and increased PAP with decrease in FEV1 and FEV1/VC. 5 Terzano C et al (2014) investigated 56 patients with a COPD exacerbation, and concluded that, chronic respiratory failure shows a relationship with pulmonary hypertension and function of the right heart. 17 Similarly in our study PH, RV dilation, RV hypertrophy was positively correlated with stages of COPD and negatively with spirometric variables. Higham MA et al studied TR by Doppler echocardiography in 73 COPD patients and concluded that, measurable TR was observed in 77%. PH was seen in 55.35% cases. There were statistically significant negative correlations of TTPG with FEV1 (-0.26, p<0.05).
13 Similarly in our study PAP measured by TR suggestive of PH was present in 22 (36.66%) subjects with severity of PH negatively correlated with Correlation of TDI parameters and Pulmonary hypertension: Melek M et al studied the relationship between tricuspid lateral annulus TDI parameters and PASP as estimated by continuous wave Doppler in 51 patients with COPD and found that, Sm, Em, and Em/Am values were found to be lower and IVRTm values higher in patients with PH. There was a significant negative correlation between PASP and Sm (r = -0.82, p<0.001). The cases where noninvasive PASP measurement is not possible, TDI can be used as an alternative and reliable method to assess PAP. 18 These findings are comparable with our result with significant number of subjects with COPD had bi-ventricular diastolic dysfunction diagnosed by Tissue Doppler imaging, Sm, Em, and Em/Am values were found to be lower and IVRTm values were higher in patients with PH. dysfunction of LV. The LV-MPI truly reflected LV systolic and diastolic dysfunction in patients with pulmonary hypertension. They concluded that, the systolic and diastolic function of LV declined, following pulmonary hypertension. 25 These findings are comparable with our results in which, RV-MPI was positively correlated with PH and negatively correlated with E/Ea ratio.
Relation of biventricular systolic and diastolic function with COPD:
Pulmonary hypertension (PH) is an important complication in the natural history of chronic obstructive pulmonary disease (COPD). Its presence is associated with reduced survival. The prevalence of PH is high in patients with advanced COPD. In COPD, PH is usually of moderate severity and progresses slowly, without altering right ventricular function in the majority of patients. 26 Schena M et al evaluated the LV impairment in 30 patients with chronic cor pulmonale and PH secondary to COPD. A linear regression analysis detected a significant correlation between mPAP and RV/LV diastolic and systolic area indexes, mitral A/E index, and LV diastolic and systolic eccentricity indexes. They stated that, functional diastolic impairment of the LV is closely correlated to PH. 27 These findings are similar to our result in which 3/4 th of subjects with COPD had bi-ventricular diastolic dysfunction and 1/3 dr had pulmonary hypertension which showed liner relationship with diastolic dysfunction. . Similarly, RV performance index deteriorated significantly with the PH group (p<0.01). Significant correlations were observed between mPAP and RV isovolumic acceleration, performance index and RV wall thickness (p<0.01). 29 These findings are comparable with our results. Modalities of measurement of pulmonary artery pressure: Tramarin R et al studied 100 COPD patients with mPAP ranging from 10 to 62 mmHg at cardiac catheterization, PAP estimation was attempted by Doppler echocardiographic methods. TR was detected in 47 (47%) patients but its quality was adequate for measurement in 30 (30%). Pulmonary regurgitation jet velocity was measurable only in five cases. Of Doppler echocardiographic data, best correlations with mean pulmonary artery pressure were found for the transtricupid gradient (0.73), for right ventri cular IVRT (0.61). Doppler evaluation of transtricuspid jet velocity allows a reasonable quantitative assessment of pulmonary artery pressure. 30 Similarly majority of subjects in our cohort of COPD had PH measured by TR jet and relatively small proportion had pulmonary regurgitation (PAEDP). Significant TR and PR were observed in 17 and 5 subjects respectively with COPD. Trivedi HS et al (1992) evaluated 20 subjects with COPD (54.5 year ± 4.92) by M-Mode echocardiography. A 2D Index was calculated RV (right ventricular maximum short axis)×TA (tricuspid annulus)+Aw (right ventricular anterior wall) and the same correlated with mean pulmonary artery pressure (r=0.97). This appears to be a useful non-invasive method for estimating PH in cases of COPD. 31 Similarly RV wall thickness and RV dilation was positively correlated with PH in our cohort of COPD. Sertogullarindan B et al (2012) retrospectively studied 600 stable COPD patients and found that, PH was more prominent in moderate level COPD cases (56.2% and 37.5%).
Relation of Diastolic function, TDI parameters with COPD:
In present study all subjects were with preserved LVEF and 47 (78.33%) subjects had bi-ventricular diastolic dysfunction. The severity of PH and diastolic dysfunction was positively correlated with severity of COPD. Similarly Schoos MM et al evaluated 90 COPD patients by TTE with preserved left ventricular (LV) ejection fraction and 66% patients with diastolic dysfunction. TR increased with COPD severity. 19 Caram LM et al (2013) studied the prevalence of echocardiographic abnormalities in COPD. The most frequent echocardiographic finding was left diastolic dysfunction (88%). The proportion of right ventricular overload (p<0.05) was higher in patients with greater obstruction. They concluded that, the COPD patients have a high prevalence of left ventricular diastolic dysfunction, which is associated with disease severity. 20 Similarly in our cohort of COPD 47 (78.33%) had diastolic dysfunction and was more prevalent in stage II and IV of GOLD criteria with multivariate analysis shows spirometric variables were negatively correlated with TDI (E/Ea ratio), PAP, E/A ratio and RVMPI ['p'< 0.0013] and positively correlated with IVRT and DT ['p'< 0.0023]. The high prevalence and the prognostic implications of ventricular dysfunction, routine assessment with echocardiogram should be considered in COPD patients.
14 These findings are comparable with our result, in which the incidence of diastolic function measured by E/Ea ratio by tissue Doppler was more in stage II and IV of COPD subjects. RV function in subjects with COPD: In present study RV diameter and RV thickness was positively correlated with PH and diastolic dysfunction and bi-ventricular systolic function was negatively correlated with PH and FEV1 and positively correlated with E/Ea ratio. Suchoń et al evaluated LV function in 35 COPD patients (62.1 +/-7.7 y). RV end-diastolic diameter and RV wall thickness were significantly larger and RVSP (38 +/-11.2 vs. 20 +/-2.5 mm Hg) was higher in the COPD group. E/A ratio and Em/Am ratio were significantly lower in COPD with inverse correlation with RVSP (r = -0.75; p<0.001). In COPD patients LV diastolic function was impaired and its magnitude was related with increase in PAP, preserved LV systolic function.
21 E/A and E/Ea ratio had negative correlation with spirometric variables and RVSP. Geyik B et al quoted that, the RVOT-FS was impaired in COPD patients, and was correlated positively with tricuspid annular plane systolic excursion (TAPSE) and pulmonary acceleration time and inversely with PAP. 22 These findings are comparable with our study. Relation of TDI parameters and MPI with COPD: Yilmaz R et al reported that, RVMPI was higher in COPD patients with PH (0.94 +/-0.27). Patients with COPD, LVMPI was positively correlated with PH, and negatively correlated with tricuspid annular plane systolic excursion and FEV1. Diastolic functions are impaired in COPD, especially in patients with pulmonary hypertension. COPD is the most common cause of secondary PH and is associated with a worse prognosis.
23
Similarly in our study RVIMP was positively correlated with PH, and negatively correlated with E/Ea ratio. In our study about 3/4 th of subjects with COPD had bi-ventricular diastolic dysfunction. Echocardiography is the first screening method for PH in patients with COPD and it should be widely used. Given the high negative predictive value of the echocardiographic estimation of systolic pulmonary arterial pressure (sPAP) in the diagnosis of PH. Echocardiography will help to avoid unnecessary invasive procedure like right cardiac catheterization which is the "gold standard" method in assessing PH. PH secondary to COPD is usually mild, but a small proportion of patients have severe PH, with worse prognosis. 24 Chang SM et al in their case control study found that, PASP correlated negatively to peak systolic velocity of lateral tricuspid annulus (RV-Sm) and RVEF. The MPI of RV and LV in patients with severe pulmonary hypertension became higher as the result of the prolongation of IVRT. The higher E/Em in pulmonary hypertension indicated diastolic Patil et al.: Echocardiogram, tissue Doppler imaging and COPD RV function and structure in patients with COPD. RV isovolumic acceleration (IVA) and performance index can detect subclinical disease and separate controls from those with no PH. 29 It is well recognized that patients with severe left ventricular (LV) systolic dysfunction develop pulmonary venous hypertension or postcapillary pulmonary hypertension, which leads to an increase in pulmonary vascular resistance (PVR) and right ventricular (RV) systolic failure. This form of biventricular failure is a result of diastolic failure in patients with preserved LV ejection fraction and systolic failure on the right. 40 Similar to our results Tayyareci Y et al reported that, the TDI-derived RV systolic velocities were impaired in COPD (P=0.0001) compared to controls. Isovolumic myocardial acceleration (IVA) was found to be significantly correlated with FEV1 (r=0.41), FEV1/FVC (r=0.43), PAP (r=-0.34), and tricuspid annular systolic excursion (r=-0.41). TDI-derived RV IVA is a novel, noninvasive echocardiographic index which may be used in the assessment of subclinical RV dysfunction in patients with COPD. 41 Gondi S et al stated that, the RV performance (Tei) index and RV-TDI indices have been shown to be useful in the detection of subclinical and clinical COPD. 42 These findings are comparable with our observation. Similar to our results, Fahmy EM et al reported that, echocardiography-derived PASP, myocardial PW DTI-derived IVRTc and blood pool-derived IVRTc were significantly higher in patients with COPD than in control subjects with strong positive correlation between PASP and PW DTI-derived IVRTc (r=0.86), and strong negative correlation with RV Tei index (r=-0.73). Tricuspid annular PW DTI-derived IVRTc correlates very strongly with both invasively measured PASP. Therefore, IVRT can be used to predict PASP as an alternative to TR-derived PASP when tricuspid regurgitation is nonrecordable. 43 There were strong correlations between COPD and associated RV dysfunction. COPD may cause RV dysfunction in the absence of pulmonary hypertension. ERS/ESC guidelines for PH recommend cardiac ultrasound as a screening method for detecting PH in patients with COPD. This method could be useful in the estimation of the prognosis and in careful monitoring of these patients with increased morbidity. The definitive diagnostic of pulmonary hypertension relies on right heart catheterization (RHC), the "gold standard" method for PH diagnosis. 36 Simple echocardiography as per recommendation of ASE seems to be a satisfactory tool to find out the cardiac involvement in COPD before undertaking any invasive and sophisticated methods. COPD assessment guidelines should include assessment of pulmonary hypertension and RV function by non invasive method like TDI echocardiography. COPD patients have a high prevalence of echocardiographic abnormalities regardless of disease severity. COPD patients have a high prevalence of bi-ventricular diastolic dysfunction, which is associated with disease severity.
CONCLUSION
This study reveals three fourth of subjects with COPD had diastolic dysfunction. Tissue Doppler imaging (E/Ea ratio) and VP are better parameters to detect early diastolic dysfunction along with other parameters. Diastolic dysfunction was positively correlated with stages of COPD. Right ventricular MPI was abnormal in two third of subjects with COPD. RV dilatation and wall thickness was negatively correlated with FEV1, FEV1/FVC and PEFR. Significant number of subjects had mild to moderate pulmonary artery hypertension. Stages of COPD were well positively correlated with pulmonary artery pressure. Spirometric parameters were negatively correlated with PH. Duration of COPD was positively correlated with PAP. RV wall thickness and RV diameter was positively correlated with duration and stages of COPD by GOLD criteria and negatively correlated with spirometric variables. RVMPI can be vital prognostic factors for RV function apart from sPAP and TDI. Our study concludes that, echocardiogram as per recommendation of ASE The influence of FVC % on the risk of a person having PH increased with increasing COPD level.
32 Similarly in present study 22 (36.66%) subjects with COPD had PH. Of total 22 (36.66%) subjects total 9 with stage-I and II COPD had mild PH, 7 with stage-III had moderate PH and 6 with stage IV had severe PH. Relation of COPD with PH and diastolic dysfunction: present study finds significant incidence of pulmonary hypertension and diastolic dysfunction in cohort of COPD subject and positively correlated with severity. Necla Özer et al studied 48 patients with severe COPD and found that, patient with PH had bi-ventricular diastolic dysfunction. 33 Similarly in our study incidence of bi-ventricular diastolic dysfunction was more in stage II-IV with moderate to severe PH compared to stage I-II with mild PH. Pulmonary hypertension is a common complication of chronic obstructive pulmonary disease (COPD). The increase in pulmonary artery pressures is often mild to moderate. However, 5-10% of patients with advanced COPD may suffer from severe pulmonary hypertension and present with a progressively downhill clinical course because of right heart failure. 34 Shrestha B et al studied the echocardiography based cardiac function in 507 COPD patients (66.1 ± 10.9 yr). More than half of the total patients showed features of chronic cor pulmonale (56.3%) and diastolic dysfunction (38.7%). Mild pulmonary artery hypertension (PAH) was detected in approximately half of patients (49.1%), followed by moderate PAH in 17.6% patients. These findings are comparable with our results except for relatively low incidence of corpulmonale due to less duration of COPD and age group with ≤ 60 years in present study.
35
Incidence of Pulmonary hypertension in COPD: PH secondary to chronic obstructive pulmonary disease (COPD) is placed in group 3 of the WHO classification of PH, that is, PH associated with lung diseases and/or hypoxemia. PH in COPD has been variably defined as resting mean pulmonary artery pressure (mPAP) > 20-25 mmHg. The prevalence of PH in stable COPD varies from 20 to 91% depending on the definition of PH, the severity of COPD and the method of measuring the pulmonary artery pressure (echocardiography versus right heart catheterization). In present study total 22 (36.66%) subjects had pulmonary hypertension. Stage -II and IV had significant prevalence of pulmonary hypertension compared to stage-I and II with 'p'=0.000234 . Significance of PH in COPD the presence of PH was associated with poor prognosis in COPD. Degree of PH in COPD: Resting PH in stable COPD is usually mild to moderate (mPAP 20-35 mmHg) and is usually not seen until the disease is advanced (FEV1 < 50%). Severe PH (mPAP > 35-45 mmHg) is rare (3%-13%) and poor prognosis has been recognized.
36, 37
Relation of parameters of diastolic dysfunction with COPD and PH: Tanaka Y et al reviewed the 49 male subjects with COPD and found that, RV-ET, RV -IVCT, RV-IVRT and RV total ejection isovolume index significantly low in subjects with pulmonary hypertension. 38 These findings are comparable with our study. In which, IVRT and DT were reduced with severity of COPD and positively correlated with FEV1. Suchoń E et al evaluated LV function in patients with COPD in patients (62.1 ± 7.7 yr) with COPD. RV end-diastolic diameter and RV wall thickness were significantly larger and right ventricle systolic pressure RVSP (38 ± 11.2 vs 20 ± 2.5 mm Hg) significantly higher in the COPD group. E/A ratio and Em/Am ratio were significantly lower in COPD. There was a strong inverse correlation between Em/Am and RVSP (r = -0.75; p<0.001) and between E/A (r = -0.6; p<0.001) as well. 39 Similarly in our study RVSP was negatively correlated with E/A, E/Ea and FEV1. Similar to our results Hilde JM et al observed that, RV impairment, increased RV wall thickness and RV dimensions present even at slight elevations of mPAP (18 ± 3 mm Hg) in COPD, which indicates an early impact on
